SC27 Real-world experience with doravirine in Italy: comparing three-drug and two-drug regimens
A Cervo(Azienda Ospedaliero-Universitaria di Modena), Giovanni Guaraldi(University of Modena and Reggio Emilia), Marianna Menozzi(Azienda Ospedaliero-Universitaria di Modena), Elena Martini, B Fontana, Maria Vittoria Cossu(Luigi Sacco Hospital), Cristina Mussini(University of Modena and Reggio Emilia), Cristina Gervasoni(University of Padua), A. Rabbi, M. Albertini(Azienda Ospedaliero-Universitaria di Modena), Davide Moschese(Luigi Sacco Hospital), G Menegotto, Roberto Rossotti(Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda)
Cited by 0
Related Papers
Monkeypox Virus Infection in Humans across 16 Countries — April–June 2022
|New England Journal of Medicine|2022|2.2k
Premature Age-Related Comorbidities Among HIV-Infected Persons Compared With the General Population
|Clinical Infectious Diseases|2011|1.3k
Tocilizumab in patients with severe COVID-19: a retrospective cohort study
|The Lancet Rheumatology|2020|998
Marked T cell activation, senescence, exhaustion and skewing towards TH17 in patients with COVID-19 pneumonia
|Nature Communications|2020|846